Evaluation of a Standardized Strategy for Uveitis Etiological Diagnosis
Launched by HOSPICES CIVILS DE LYON · Jul 13, 2010
Trial Information
Current as of June 04, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Uveitis
- • Patient consulting one of the study's sites
- • Age \> 18 years old
- • Affiliation to the French national health insurance program
- • Patient agreeing to participate in the study
- Exclusion Criteria:
- • Positive HIV serology
- • Postsurgical or posttraumatic uveitis or endophthalmitis
- • Toxoplasmic uveitis
- • Pathology likely to be the cause of the known uveitis
- • Ophthalmic entities only diagnosed by the ophthalmic examination
- • Age \< 18 years old
- • Patient under law protection or guardianship
- • Pregnant women or those planning to be pregnant during the study
- • Severe uveitis (VA \< 20/200) with retinal vascularitis requiring an emergency treatment and assessment.
About Hospices Civils De Lyon
Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lyon, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials